Caffeinated energy drinks in the Canadian context: health risk assessment with a focus on cardiovascular effects.
Blood Pressure
/ drug effects
Caffeine
/ administration & dosage
Canada
Cardiovascular System
/ drug effects
Central Nervous System Stimulants
/ administration & dosage
Electrocardiography
Energy Drinks
Feeding Behavior
Glucuronates
/ administration & dosage
Heart Rate
/ drug effects
Humans
Inositol
/ administration & dosage
Product Surveillance, Postmarketing
Risk Assessment
Taurine
/ administration & dosage
Vitamin B Complex
/ administration & dosage
boissons énergisantes
caffeine
caféine
cardiovascular system
energy drinks
food safety
risk assessment
système cardiovasculaire
sécurité alimentaire
taurine
évaluation des risques
Journal
Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme
ISSN: 1715-5320
Titre abrégé: Appl Physiol Nutr Metab
Pays: Canada
ID NLM: 101264333
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
pubmed:
18
5
2021
medline:
21
12
2021
entrez:
17
5
2021
Statut:
ppublish
Résumé
In Canada, caffeinated energy drinks (CEDs) currently sold under Temporary Marketing Authorizations must meet strict eligibility criteria. These criteria, which include compositional and labelling requirements, were developed based on the outcome of a health risk assessment conducted by Health Canada (HC) in 2013. HC updated its assessment by reviewing new information with the focus on potential cardiovascular effects associated with the consumption of CEDs available for sale in Canada. Due to limited data on CED consumption among Canadians to derive accurate exposure information, the composition of a typical CED was characterized to assess the potential effects of single ingredients and synergistic interactions between ingredients on the cardiovascular system. Surveillance data on potential adverse effects related to CED consumption was also analyzed. After extensive review, HC's updated assessment confirms the current risk management approach for CEDs is health protective for Canadian consumers, including the potential for cardiovascular effects. The available evidence supports that moderate consumption (up to 500 mL per day) of a typical CED authorized for sale in Canada is safe for the general population of healthy adults and adolescents. It also re-confirms that vulnerable sub-populations (i.e., children, pregnant and/or breastfeeding women, and caffeine-sensitive individuals) should not consume CEDs.
Identifiants
pubmed: 34000209
doi: 10.1139/apnm-2021-0245
doi:
Substances chimiques
Central Nervous System Stimulants
0
Glucuronates
0
Vitamin B Complex
12001-76-2
Taurine
1EQV5MLY3D
glucuronolactone
32449-92-6
Caffeine
3G6A5W338E
Inositol
4L6452S749
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM